Skip to main content
Premium Trial:

Request an Annual Quote

Millipore Shares Soar on Rumors of a $6B Buyout Bid from Thermo Fisher

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Shares of Millipore climbed as high as $102.91 — a 44 percent rise from its Friday closing price of $71.34 — after a report from Bloomberg claimed that Thermo Fisher Scientific has made an unsolicited $6 billion bid to acquire the firm.

A Thermo Fisher spokesperson said the firm would not comment on the "rumor," and Millipore did not respond to a request for comment.

However, Reuters reported later in the day that a source had confirmed for them that Thermo Fisher had made the offer. Both news agencies said that Millipore has hired Goldman Sachs as a financial advisor in response to the bid.

In Monday afternoon trade, shares of Millipore pulled back some but were still up 21 percent at $86.17 on the New York Stock Exchange.

Millipore has a market cap of around $4.9 billion and recently reported full-year 2009 revenues of $1.65 billion.

Thermo Fisher earlier this month reported 2009 revenues of $10.11 billion, and it currently has a market cap of around $19.5 billion.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.